Protein Variants | Comment | Organism |
---|---|---|
additional information | caspase-10 isoforms are transiently downregulated using siRNAs targeting all caspase-10 isoforms, or siRNAs specific for individual caspase-10 isoforms. Downregulation of individual or all caspase-10 isoforms in SH-EP cells does not affect TRAIL sensitivity | Homo sapiens |
General Stability | Organism |
---|---|
caspase-10B is a highly unstable caspase-10 isoform, while isozymes caspase-10A, -D and and -G are remarkably stable | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
CrmA | caspase-10 is more resistant than caspase-8, EC 3.4.22.61, to the caspase inhibitor | Homo sapiens | |
Z-VAD-fluoromethylketone | caspase-10 is more resistant than caspase-8, EC 3.4.22.61, to the caspase inhibitor | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
adrenal gland | high expression level | Homo sapiens | - |
B-lymphoma cell | - |
Homo sapiens | - |
BJAB cell | - |
Homo sapiens | - |
JURKAT cell | low expression level | Homo sapiens | - |
lymphocyte | from peripheral blood, high expression level | Homo sapiens | - |
neuroblastoma cell | low expression level | Homo sapiens | - |
SH-EP cell | neuroblastoma cells | Homo sapiens | - |
SK-N-AS cell | neuroblastoma cells | Homo sapiens | - |
SW-480 cell | low expression level | Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
DEVD-4-nitroanilide + H2O | - |
Homo sapiens | DEVD + 4-nitroaniline | - |
? |
General Information | Comment | Organism |
---|---|---|
malfunction | caspase-10 silencing in neuroblastoma is cell-type related. Downregulation of individual or all caspase-10 isoforms in SH-EP cells does not affect TRAIL sensitivity | Homo sapiens |
additional information | isozymes caspase-10B and -10A/B are protected from CHX-mediated degradation by lactacystin treatment | Homo sapiens |
physiological function | individual caspase-10 isoforms play distinct and opposing roles in the initiation of death receptor-mediated tumour cell apoptosis in several tumour cell types. Distinct caspase-10 isoforms induce opposed apoptotic signals in NB cells. Isozymes caspase-10A and -10D strongly increase tumour necrosis factor-related apoptosis-inducing ligand, i.e. TRAIL, and FasL sensitivity, whereas caspase-10B or -10G have no effect or are weakly anti-apoptotic. The unique C-terminal end of caspase-10B is responsible for its degradation by the ubiquitin-proteasome pathway and for its lack of pro-apoptotic activity compared with caspase-10A and -10D. Functional comparison to caspase-8, EC 3.4.22.61, overview. Caspase-10A or -10D isoforms can substitute for caspase-8 in the initiation extrinsic apoptosis | Homo sapiens |